CDXS

Codexis Inc

1.28

Oct 23 • 3:59 PM ET -0.03 (-2.29%)

1.30

Aftermarket • 7:27 PM ET +0.02 (1.56%)

Healthcare Biotechnology USA Micro NASD

Peers: MRVI DNA TWST CBUS A ABSI SEER TECH TKNO DHR

| Held by: VTI IWM VXF IWO IBB VTWO IWC FESM IWN BUSM

Scroll to Statements

Index	RUT
Market Cap	140.17M
Enterprise Value	157.42M
Income	-30.72M
Sales	77.68M
Book/sh	0.36
Cash/sh	0.51
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	146
IPO	Apr 22, 2010

P/E	-
Forward P/E	-
PEG	-
P/S	1.80
P/B	3.55
P/C	2.53
P/FCF	-
EV/EBITDA	-
EV/Sales	2.03
Quick Ratio	2.99
Current Ratio	3.06
Debt/Eq	2.20
LT Debt/Eq	1.89
Option/Short	Yes / Yes

EPS (ttm)	-0.34
EPS next Y	-0.28
EPS next Q	-0.10
EPS this Y	24.86%
EPS next Y	26.36%
EPS next 5Y	39.03%
EPS past 3/5Y	0.62% -4.52%
Sales past 3/5Y	-20.22% 0.38%
EPS Y/Y TTM	58.70%
Sales Y/Y TTM	35.89%
EPS Q/Q	15.19%
Sales Q/Q	-2.69%
Earnings	Aug 11 AMC
EPS/Sales Surpr.	8.26% 7.89%

Insider Own	7.10%
Insider Trans	-0.20%
Inst Own	62.36%
Inst Trans	-1.89%
ROA	-23.79%
ROE	-69.36%
ROIC	-32.27%
Gross Margin	80.47%
Oper. Margin	-31.23%
Profit Margin	-39.55%
SMA20	-4.48%
SMA50	-10.63%
SMA200	-30.01%
Trades

Shs Outstand	109.51M
Shs Float	101.73M
Short Float	4.76%
Short Ratio	4.22
Short Interest	4.84M
52W High	2.98 -57.05%
52W Low	0.96 33.57%
Volatility	7.16% 6.42%
ATR (14)	0.09
RSI (14)	43.78
Beta	2.37
Rel Volume	0.48
Avg Volume	1.15M
Volume	546,633

Perf Week	3.23%
Perf Month	-6.57%
Perf Quarter	-17.42%
Perf Half Y	-51.15%
Perf YTD	-21.47%
Perf Year	-50.58%
Perf 3Y	-23.81%
Perf 5Y	-95.70%
Perf 10Y	-71.24%
Recom	1.50
Target Price	6.14
Prev Close	1.31
Price	1.28
Change %	-2.29%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-19-24	Downgrade	The Benchmark Company	Buy → Hold
Jun-03-24	Resumed	Jefferies	Buy	$5
May-30-24	Initiated	Cantor Fitzgerald	Overweight	$11
Feb-29-24	Upgrade	The Benchmark Company	Hold → Buy
Nov-07-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-07-23	Downgrade	TD Cowen	Outperform → Market Perform	$21 → $4
May-09-23	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-31-22	Resumed	Piper Sandler	Overweight	$35
Mar-02-22	Resumed	Cowen	Outperform
Apr-12-21	Initiated	Piper Sandler	Overweight	$32
Mar-01-21	Initiated	Stifel	Buy	$30
Feb-26-21	Reiterated	H.C. Wainwright	Buy	$21 → $26
Mar-10-20	Initiated	The Benchmark Company	Buy
Jan-17-19	Upgrade	First Analysis Sec	Neutral → Outperform	$12 → $19
May-16-18	Initiated	Stephens	Overweight	$16
Oct-13-17	Reiterated	H.C. Wainwright	Buy	$8 → $8.50
May-31-17	Initiated	Jefferies	Buy	$8
Jan-26-17	Downgrade	First Analysis Sec	Overweight → Equal-Weight	$5.50
Jan-04-17	Upgrade	Ladenburg Thalmann	Neutral → Buy
Jan-06-16	Initiated	H.C. Wainwright	Buy	$6

Show Previous Ratings

Sep-28-26 06:00AM	Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA (GlobeNewswire)
Sep-25-26 06:29PM	What Needs To Be True To Buy Twist Bioscience Stock Now? (Trefis)
Aug-27-26 09:00AM	Codexis to Participate in Cantor Global Healthcare Conference 2026 (GlobeNewswire)
Aug-12-26 01:02AM	Codexis Inc (CDXS) (Q2 2026) Earnings Call Highlights: Biocatalysis Growth and ECO Synthesis ... (GuruFocus.com) +8.11%
Aug-11-26 04:42PM	Codexis: Q2 Earnings Snapshot (Associated Press)
04:05PM	Loading…
04:05PM	Codexis Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-03-26 09:00AM	Codexis Appoints David Butler, PhD, to Strategic Advisory Board (GlobeNewswire)
Jul-28-26 09:00AM	Codexis to Report Second Quarter 2026 Financial Results on August 11 (GlobeNewswire)
Jul-23-26 11:47PM	Codexis Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -25.63%
04:13PM	Codexis Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-20-26 09:00AM	Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA (GlobeNewswire)
May-07-26 05:34PM	Codexis: Q1 Earnings Snapshot (Associated Press) +10.47%
04:05PM	Codexis Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-29-26 09:00AM	Codexis to share RNA manufacturing advances at TIDES USA (GlobeNewswire)
Apr-23-26 09:00AM	Codexis to Report First Quarter 2026 Financial Results on May 7 (GlobeNewswire)
11:01PM	Loading…
Mar-11-26 11:01PM	Codexis Inc (CDXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com) +34.65%
04:37PM	Codexis: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results (GlobeNewswire)
Mar-07-26 08:03PM	Codexis Targets 2026 Inflection as CEO Touts ECO Synthesis Push in RNA Manufacturing at TD Cowen Conf (MarketBeat)
Mar-05-26 07:45AM	Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates (Zacks) +16.67%
Mar-04-26 10:06AM	Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis Manufacturing Platform (PR Newswire) +10.20%
Feb-26-26 09:55AM	Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-25-26 09:00AM	Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 (GlobeNewswire)
Feb-24-26 08:50AM	Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
Feb-17-26 09:00AM	Codexis to Participate in TD Cowen 46th Annual Health Care Conference (GlobeNewswire)
Feb-10-26 09:00AM	Codexis Achieves ISO 9001:2015 Certification (GlobeNewswire)
08:15AM	Incyte (INCY) Q4 Earnings Lag Estimates (Zacks)
Jan-07-26 09:00AM	Codexis Expands Reach of the ECO Synthesis Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics (PR Newswire)
Nov-11-25 09:35AM	Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS) (Zacks)
Nov-10-25 09:00AM	Codexis Announces Signing of Lease for GMP Manufacturing Facility (GlobeNewswire)
12:02AM	Loading…
Nov-07-25 12:02AM	Codexis Inc (CDXS) Q3 2025 Earnings Call Highlights: Strategic Shifts and New Partnerships ... (GuruFocus.com) -16.95%
Nov-06-25 08:00PM	Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -5.35%
06:55PM	Codexis: Q3 Earnings Snapshot (Associated Press Finance)
04:21PM	Codexis Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-05-25 08:15AM	EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-04-25 05:55PM	Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Oct-29-25 09:58AM	Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis Manufacturing Platform for Therapeutic siRNA Manufacturing (PR Newswire) -6.56%
Oct-23-25 07:05AM	Codexis to Report Third Quarter 2025 Financial Results on November 6 (GlobeNewswire)
Aug-28-25 09:00AM	Codexis to Participate in Cantor Global Healthcare Conference (GlobeNewswire)
Aug-14-25 03:12AM	Codexis Inc (CDXS) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Initiatives (GuruFocus.com)
Aug-13-25 05:15PM	Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +6.64%
04:23PM	Codexis: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports Second Quarter 2025 Financial Results (GlobeNewswire)
07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
Aug-12-25 03:00PM	BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-11-25 08:10AM	Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-07-25 07:30AM	Switch Bioworks Expands Leadership Team and Moves into New Facility to Accelerate Development of its Microbial Fertilizer Products (PR Newswire)
Aug-04-25 05:15PM	Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +5.58%
Aug-01-25 07:45AM	Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates (Zacks)
Jul-30-25 04:05PM	Codexis to Report Second Quarter 2025 Financial Results on August 13 (GlobeNewswire)
May-22-25 07:00AM	Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA (GlobeNewswire) +5.13%
May-21-25 04:05PM	Codexis to Participate in Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-25 01:03PM	Q1 2025 Codexis Inc Earnings Call (Thomson Reuters StreetEvents)
03:15AM	Codexis Inc (CDXS) Q1 2025 Earnings Call Highlights: Navigating Revenue Volatility with ... (GuruFocus.com)
May-14-25 05:40PM	Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:39PM	Codexis: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-13-25 05:10PM	Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-12-25 05:45PM	Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +7.32%
May-07-25 07:00AM	Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting (GlobeNewswire)
Apr-30-25 04:05PM	Codexis to Report First Quarter 2025 Financial Results on May 14 (GlobeNewswire)
Apr-24-25 10:01AM	Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:15AM	NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-09-25 05:00PM	Codexis Announces Byron Dorgan to Retire from Board of Directors (GlobeNewswire) +17.26%
Apr-03-25 10:01AM	Arcutis Biotherapeutics (ARQT) Moves 10.8% Higher: Will This Strength Last? (Zacks) -8.03%
Apr-01-25 07:00AM	Codexis Appoints Cynthia Collins to Board of Directors (GlobeNewswire) -6.69%
Mar-24-25 07:00AM	Codexis Announces First Revenue-Generating Contract for ECO Synthesis Manufacturing Services (GlobeNewswire) +20.39%
Mar-07-25 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) -6.74%
Feb-28-25 11:02AM	Q4 2024 Codexis Inc Earnings Call (Thomson Reuters StreetEvents) -22.65%
02:36AM	Codexis Inc (CDXS) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Revenue Growth ... (GuruFocus.com)
Feb-27-25 06:35PM	Codexis (CDXS) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -5.53%
05:36PM	Codexis: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:05PM	Codexis to Participate in TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-14-25 05:15PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) +5.12%
Feb-13-25 04:05PM	Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th (GlobeNewswire)
Feb-06-25 04:05PM	Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board (GlobeNewswire)
Jan-16-25 04:05PM	Codexis Appoints Christos Richards to Board of Directors (GlobeNewswire)
Jan-10-25 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) -7.77%
Dec-06-24 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) +15.22%
Nov-19-24 04:05PM	Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +8.14%
Nov-14-24 04:05PM	Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics (GlobeNewswire) -7.43%
Nov-12-24 04:05PM	Codexis Announces Appointment of Raymond De Vre, PhD, to Board of Directors (GlobeNewswire)
04:05PM	Codexis Announces Appointment of Raymond De Vr , PhD, to Board of Directors (GlobeNewswire)
Nov-11-24 04:05PM	Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics (GlobeNewswire)
Nov-08-24 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire)
Nov-04-24 04:05PM	Codexis to Participate in Upcoming Healthcare Conferences (GlobeNewswire) +9.46%
Nov-01-24 09:01AM	Codexis Inc (CDXS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Focus ... (GuruFocus.com) +11.46%
Oct-31-24 05:30PM	Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:23PM	Codexis: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-24-24 04:05PM	Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting (GlobeNewswire)
Oct-22-24 04:05PM	Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors (GlobeNewswire) -7.27%
Oct-15-24 07:10AM	Codexis announces employment inducement grants (TipRanks) +5.28%
Oct-14-24 07:05AM	Codexis Announces New Employment Inducement Grants (GlobeNewswire)
Oct-10-24 04:05PM	Codexis to Report Third Quarter 2024 Financial Results on October 31 (GlobeNewswire) +6.06%
Oct-09-24 05:56PM	Codexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... (GuruFocus.com)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Erbez Georgia	See Remarks	Oct 12 '26	Sale	1.36	6,335	8,619	60,475	Oct 14 05:19 PM
MOORE ALISON	President and CEO	Oct 12 '26	Sale	1.36	6,335	8,619	244,171	Oct 14 05:17 PM
Erbez Georgia	Officer	Oct 12 '26	Proposed Sale	1.36	6,335	8,619		Oct 13 04:32 PM
MOORE ALISON	Officer	Oct 12 '26	Proposed Sale	1.36	6,335	8,619		Oct 13 04:27 PM
De Vre Raymond	Director	Jun 11 '26	Sale	2.37	2,605	6,174	84,811	Jun 11 08:19 PM
Lutz Stefan	Chief Scientific Officer	Feb 24 '26	Sale	1.13	5,862	6,641	130,421	Feb 25 07:54 PM
Lutz Stefan	Officer	Feb 24 '26	Proposed Sale	1.17	5,280	6,178		Feb 23 08:08 PM
Lutz Stefan	Chief Scientific Officer	Feb 06 '26	Sale	1.31	2,492	3,257	136,283	Feb 09 04:07 PM
Erbez Georgia	See Remarks	Feb 06 '26	Sale	1.31	3,826	5,001	66,810	Feb 09 04:07 PM
MOORE ALISON	President and CEO	Feb 06 '26	Sale	1.31	3,826	5,001	250,506	Feb 09 04:06 PM
Norrett Kevin	Officer	Feb 06 '26	Proposed Sale	1.27	3,291	4,180		Feb 06 06:18 PM
Lutz Stefan	Officer	Feb 06 '26	Proposed Sale	1.27	2,460	3,124		Feb 06 06:15 PM
KEVIN NORRETT	Officer	Jan 16 '26	Proposed Sale	1.67	1,745	2,914		Jan 16 05:09 PM
Lutz Stefan	CSO	Jan 07 '26	Sale	1.70	4,685	7,950	138,775	Jan 08 06:51 PM
Norrett Kevin	Officer	Jan 07 '26	Proposed Sale	1.70	6,123	10,409		Jan 07 09:17 PM
Opaleye Management Inc.	10% Owner	Dec 01 '25	Sale	1.67	253,533	422,766	179,989	Dec 01 05:41 PM
Opaleye Management Inc.	10% Owner	Nov 28 '25	Sale	1.75	107,490	188,108	188,522	Dec 01 05:41 PM
Opaleye Management Inc.	10% Owner	Nov 26 '25	Sale	1.74	5,000	8,706	191,012	Dec 01 05:41 PM
WOLF DENNIS P	Director	Nov 21 '25	Sale	1.56	8,952	13,988	138,951	Nov 25 04:18 PM
DENNIS P WOLF	Officer	Nov 21 '25	Proposed Sale	1.56	8,952	13,988		Nov 21 04:51 PM
Opaleye Management Inc.	10% Owner	Nov 12 '25	Sale	1.96	192,459	376,924	196,012	Nov 14 04:15 PM
De Vre Raymond	Director	Nov 11 '25	Sale	1.74	1,413	2,459	87,416	Nov 13 04:16 PM
Opaleye Management Inc.	10% Owner	Nov 11 '25	Sale	1.80	548,211	986,451	223,461	Nov 12 04:05 PM
Opaleye Management Inc.	10% Owner	Nov 10 '25	Sale	1.73	208,318	361,369	236,682	Nov 12 04:05 PM
Opaleye Management Inc.	10% Owner	Nov 07 '25	Sale	1.70	10,000	16,968	240,000	Nov 12 04:05 PM

Codexis, Inc. is an enzyme engineering company, which engages in technology solutions to improve therapeutics manufacturing. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

PresidentDr. Alison Moore Ph.D.

CFO & Chief Business OfficerMs. Georgia L. Erbez

Chief Scientific OfficerDr. Stefan Lutz Ph.D.

Senior Vice President of Sales & MarketingMr. Britton Jimenez

Senior VP & Head of Human ResourcesMs. Karen Frechou-Armijo

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDXS

Codexis Inc

Upgrade your Finviz experience